Filing Flows › Comparisons › PBSV vs RTB
Pharma-Bio Serv vs RTB Digital: PBSV and RTB compared
Pharma-Bio Serv is the larger company: $2.3M of revenue in its latest quarter (Q3 FY26) against $2.3M for RTB Digital (Q2 2026). RTB Digital is growing faster (+350% against +19% a year earlier). Pharma-Bio Serv is more profitable, with an operating margin of -3.1% against -383.6%.
Where the money goes: PBSV and RTB
Pharma-Bio Serv (PBSV) · Q3 FY26
Pharma-Bio Serv, Q3 FY26: revenue $2.3M (+19% year over year), operating margin -3.1%, net loss $14K, operating cash flow $61K. The chart follows the revenue to costs, profit and cash.
RTB Digital (RTB) · Q2 2026
RTB Digital, Q2 2026: revenue $2.3M (+350% year over year), operating margin -383.6%, net loss $9.6M, operating cash flow −$3.1M. The chart follows the revenue to costs, profit and cash.
| Pharma-Bio Serv (PBSV) | RTB Digital (RTB) | |
|---|---|---|
| Latest quarter | Q3 FY26 | Q2 2026 |
| Revenue | $2.3M | $2.3M |
| Revenue growth, Y/Y | +19% | +350% |
| Operating margin | -3.1% | -383.6% |
| Net earnings | −$14K | −$9.6M |
| Net margin | -0.6% | -411.6% |
| Operating cash flow | $61K | −$3.1M |
| Free cash flow | $60K | — |
Where the revenue comes from
RTB Digital
- Fintech Operations: $1.7M (73%)
- Platform Operations: $630K (27%)
Questions
Which is bigger, Pharma-Bio Serv or RTB Digital?
Pharma-Bio Serv is the larger company: $2.3M of revenue in its latest quarter (Q3 FY26) against $2.3M for RTB Digital (Q2 2026).
Is Pharma-Bio Serv or RTB Digital growing faster?
RTB Digital is growing faster (+350% against +19% a year earlier).
Which is more profitable, Pharma-Bio Serv or RTB Digital?
Pharma-Bio Serv is more profitable, with an operating margin of -3.1% against -383.6%.
More: Pharma-Bio Serv earnings · how Pharma-Bio Serv makes money · RTB Digital earnings · how RTB Digital makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Sep 14, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.